

  Host: Peter Buch, MD, FACG, AGAF, FACP <br>

  Guest: William Grady, MD <br>


  
    <p>While colorectal cancer is the second most common cause of cancer deaths, only a third of people between the ages of 45 and 75 are compliant with screening recommendations. However, cell-free DNA blood-based tests could become a new option for colorectal cancer screening. Dr. Peter Buch sits down with GI expert Dr. William Grady to discuss the efficacy of this new test and where it is in the FDA approval process.</p>

<description>

  Host: Peter Buch, MD, FACG, AGAF, FACP &lt;br&gt;

  Guest: William Grady, MD &lt;br&gt;


  
    &lt;p&gt;While colorectal cancer is the second most common cause of cancer deaths, only a third of people between the ages of 45 and 75 are compliant with screening recommendations. However, cell-free DNA blood-based tests could become a new option for colorectal cancer screening. Dr. Peter Buch sits down with GI expert Dr. William Grady to discuss the efficacy of this new test and where it is in the FDA approval process.&lt;/p&gt;</description>

GI Insights

Developments in Colorectal Cancer Screening: Cell-Free DNA Blood Testing

Developments in Colorectal Cancer Screening: Cell-Free DNA Blood Testing

Description